Minji Kim
Corporate Officer/Principal chez MINERALYS THERAPEUTICS, INC.
Profil
Minji Kim is currently the Chief Business Officer at Mineralys Therapeutics, Inc. Prior to this, she worked as the Vice President of Corporate and Business Development at Curis, Inc. and as an Associate in Global Business Development and Licensing at Hoffmann-La Roche, Inc. She holds a Master's in Business Administration from Yale University and a doctorate from Seoul National University.
Postes actifs de Minji Kim
| Sociétés | Poste | Début |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Corporate Officer/Principal | 04/01/2024 |
Anciens postes connus de Minji Kim
| Sociétés | Poste | Fin |
|---|---|---|
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| CURIS, INC. | Corporate Officer/Principal | - |
Formation de Minji Kim
| Seoul National University | Doctorate Degree |
| Yale University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CURIS, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |